62 / 103
T
avares
RS
et
al
.
346
R
ev
A
ssoc
M
ed
B
ras
2017; 63(4):341-346
13.
Schechter A. Hemoglobin research and the origins of molecular medicine.
Blood. 2008; 112(10):3927-38.
14. Tran H, Silva D, Petrovsky N. Case study: potential pitfalls of using
hemoglobin Alc as the sole measure of glycemic control. Clin Diabetes. 2004;
22(3):141-3.
15.
Sacks DB, Burtis CA, Ashwood ER, editors. Tietz textbook of clinical
chemistry. Philadelphia: W. B. Saunders; 1999. p. 750-808.
16.
Hanas R, John WG; International HbA1c Consensus Committee. 2013
Update on the worldwide standardization of the hemoglobin A1c
measurement. Pediatr Diabetes. 2014; 15(3):e1-2.
17.
Hoelzel W, Weykamp C, Jeppsson J, Miedema K, Barr JR, Goodall I, et al.;
IFCC Working Group on HbA1c Standardization. IFCC reference system
for measurement of hemoglobin A1c in human blood and the national stan-
dardization schemes in the United States, Japan, and Sweden: a method-
-comparison study. Clin Chem. 2004; 50(1):166-74.
18.
Secretaria de Atenção à Saude, Departamento de Atenção. Orientações para
a coleta e análise de dados antropométricos em serviços de saúde. Brasília;
2011. p. 76.
19.
Menezes MGS, Couto FD, Junior LSS, Adôrno EV, Barbosa CG, Gonçalves
MS, et al. Determinação de HbA1c por CLAE: interferência de variantes de
hemoglobinas S e C e alta concentração de HbF. J Bras Patol Med Lab. 2012;
48(5):337-44.
20. Yedla N, Kuchay MS, Mithal A. Hemoglobin E disease and glycosylated
hemoglobin. Indian J Endocrinol Metab. 2015; 19(5):683-5.
21. Copeland KC, Silverstein J, Moore KR, Prazar GE, Raymer T, Shiffman RN,
et al. Al E. Management of newly diagnosed type 2 diabetes mellitus (T2DM)
in children and adolescents. Pediatrics. 2013; 131(2):364-82.
22. Camargo JL, Gross JL. Conditions associated with very low values of
glycohaemoglobin measured by an HPLC method. J Clin Pathol. 2004;
57(4):346-9.
23. Saw S, Loh TP, Yin C, Sethi SK. Identification of hemoglobin variants in samples
received for glycated hemoglobin testing. Clin ChimActa. 2013; 415:173-5.
24.
Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically
modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;
47(2):153-63.
25.
Behan KJ, Storey NM, Lee HK. Reporting variant hemoglobins discovered
during hemoglobin A1c analysis — common practices in clinical laboratories.
Clin Chim Acta. 2009; 406(1-2):124-8.
26.
Herman WH, Cohen RM. Racial and ethnic differences in the relationship
between HbA1c and blood glucose: implications for the diagnosis of diabetes.
J Clin Endocrinol Metab. 2012; 97(4):1067-72.
27. American Diabetes Association (ADA). Standards of medical care in
diabetes--2011. Diabetes Care. 2011; 34(Suppl 1):S11-61.
28.
Nakanishi T, Miyazaki A, Iguchi K, Shimizu A. Effect of hemoglobin variants
on routine glycohemoglobin measurements assessed by a mass spectrometric
method. Clin Chem. 2000; 46(10):1689-92.
29.
Blincko S, Anzetse J, Edwards R. Measurement of glycated haemoglobin in
whole blood by a novel fluorescence quenching assay. Ann Clin Biochem.
2000; 37(Pt 4):492-7.
30.
Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Hemoglobin
variants and determination of glycated hemoglobin (HbA1c). Diabetes
Metab Res Rev. 2001; 17(2):94-8.
31. Sacks DB, Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical
chemistry and molecular diagnostics. St. Louis: Elsevier; 2012. p. 1415-56.
32.
Bouzid K, Ahmed HB, Kalai E, Blibeche S, Couque N, Khiari K, et al.
Prevalence of hemoglobin variants in a diabetic population at high risk of
hemoglobinopathies and optimization of HbA1c monitoring by incorporating
HPLC in the laboratory workup. Libyan J Med. 2014; 9:25768.
33.
Faillace R. Hemograma: manual de interpretação. 4. ed. Porto Alegre: Artmed;
2003. p. 14-37.